130 related articles for article (PubMed ID: 38757961)
1. Mammalian orthoreovirus capsid protein σ3 antagonizes RLR-mediated antiviral responses by degrading MAVS.
Li D; Mo R; Li X; Cheng R; Xie J; Li H; Yang Y; Li S; Li H; Yan Z; Wei S; Idris A; Li X; Feng R
mSphere; 2024 Jun; 9(6):e0023624. PubMed ID: 38757961
[TBL] [Abstract][Full Text] [Related]
2. Mammalian reovirus µ1 protein attenuates RIG-I and MDA5-mediated signaling transduction by blocking IRF3 phosphorylation and nuclear translocation.
Wu B; Li D; Bai H; Mo R; Li H; Xie J; Zhang X; Yang Y; Li H; Idris A; Li X; Feng R
Mol Immunol; 2024 Jun; 170():131-143. PubMed ID: 38663254
[TBL] [Abstract][Full Text] [Related]
3. Encephalomyocarditis Virus Abrogates the Interferon Beta Signaling Pathway via Its Structural Protein VP2.
Han Y; Xie J; Xu S; Bi Y; Li X; Zhang H; Idris A; Bai J; Feng R
J Virol; 2021 Feb; 95(6):. PubMed ID: 33328314
[TBL] [Abstract][Full Text] [Related]
4. Human Herpesvirus 6B U26 Inhibits the Activation of the RLR/MAVS Signaling Pathway.
Jiang X; Tang T; Guo J; Wang Y; Li P; Chen X; Wang L; Wen Y; Jia J; Emanuela G; Hu B; Chen S; Yao K; Li L; Tang H
mBio; 2021 Feb; 12(1):. PubMed ID: 33593967
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of the RLR signaling pathway by SARS-CoV-2 ORF7b is mediated by MAVS and abrogated by ORF7b-homologous interfering peptide.
Xiao X; Fu Y; You W; Huang C; Zeng F; Gu X; Sun X; Li J; Zhang Q; Du W; Cheng G; Liu Z; Liu L
J Virol; 2024 May; 98(5):e0157323. PubMed ID: 38572974
[TBL] [Abstract][Full Text] [Related]
6. West Nile Virus NS1 Antagonizes Interferon Beta Production by Targeting RIG-I and MDA5.
Zhang HL; Ye HQ; Liu SQ; Deng CL; Li XD; Shi PY; Zhang B
J Virol; 2017 Sep; 91(18):. PubMed ID: 28659477
[TBL] [Abstract][Full Text] [Related]
7. Subcellular Localizations of RIG-I, TRIM25, and MAVS Complexes.
Sánchez-Aparicio MT; Ayllón J; Leo-Macias A; Wolff T; García-Sastre A
J Virol; 2017 Jan; 91(2):. PubMed ID: 27807226
[TBL] [Abstract][Full Text] [Related]
8. Negative regulators of the RIG-I-like receptor signaling pathway.
Quicke KM; Diamond MS; Suthar MS
Eur J Immunol; 2017 Apr; 47(4):615-628. PubMed ID: 28295214
[TBL] [Abstract][Full Text] [Related]
9. SARS-CoV-2 ORF9b antagonizes type I and III interferons by targeting multiple components of the RIG-I/MDA-5-MAVS, TLR3-TRIF, and cGAS-STING signaling pathways.
Han L; Zhuang MW; Deng J; Zheng Y; Zhang J; Nan ML; Zhang XJ; Gao C; Wang PH
J Med Virol; 2021 Sep; 93(9):5376-5389. PubMed ID: 33913550
[TBL] [Abstract][Full Text] [Related]
10. Hepatitis C Virus Infection Is Inhibited by a Noncanonical Antiviral Signaling Pathway Targeted by NS3-NS4A.
Vazquez C; Tan CY; Horner SM
J Virol; 2019 Dec; 93(23):. PubMed ID: 31534039
[TBL] [Abstract][Full Text] [Related]
11. Dual targeting of RIG-I and MAVS by MARCH5 mitochondria ubiquitin ligase in innate immunity.
Park YJ; Oanh NTK; Heo J; Kim SG; Lee HS; Lee H; Lee JH; Kang HC; Lim W; Yoo YS; Cho H
Cell Signal; 2020 Mar; 67():109520. PubMed ID: 31881323
[TBL] [Abstract][Full Text] [Related]
12. Spatiotemporal dynamics of innate immune signaling via RIG-I-like receptors.
Esser-Nobis K; Hatfield LD; Gale M
Proc Natl Acad Sci U S A; 2020 Jul; 117(27):15778-15788. PubMed ID: 32571931
[TBL] [Abstract][Full Text] [Related]
13. Pyruvate Carboxylase Activates the RIG-I-like Receptor-Mediated Antiviral Immune Response by Targeting the MAVS signalosome.
Cao Z; Zhou Y; Zhu S; Feng J; Chen X; Liu S; Peng N; Yang X; Xu G; Zhu Y
Sci Rep; 2016 Feb; 6():22002. PubMed ID: 26906558
[TBL] [Abstract][Full Text] [Related]
14. Differential roles of RIG-I like receptors in SARS-CoV-2 infection.
Yang DM; Geng TT; Harrison AG; Wang PH
Mil Med Res; 2021 Sep; 8(1):49. PubMed ID: 34488908
[TBL] [Abstract][Full Text] [Related]
15. SARS-CoV-2 Nsp5 Demonstrates Two Distinct Mechanisms Targeting RIG-I and MAVS To Evade the Innate Immune Response.
Liu Y; Qin C; Rao Y; Ngo C; Feng JJ; Zhao J; Zhang S; Wang TY; Carriere J; Savas AC; Zarinfar M; Rice S; Yang H; Yuan W; Camarero JA; Yu J; Chen XS; Zhang C; Feng P
mBio; 2021 Oct; 12(5):e0233521. PubMed ID: 34544279
[TBL] [Abstract][Full Text] [Related]
16. Enterovirus 2Apro targets MDA5 and MAVS in infected cells.
Feng Q; Langereis MA; Lork M; Nguyen M; Hato SV; Lanke K; Emdad L; Bhoopathi P; Fisher PB; Lloyd RE; van Kuppeveld FJ
J Virol; 2014 Mar; 88(6):3369-78. PubMed ID: 24390337
[TBL] [Abstract][Full Text] [Related]
17. MAVS-mediated host cell defense is inhibited by Borna disease virus.
Li Y; Song W; Wu J; Zhang Q; He J; Li A; Qian J; Zhai A; Hu Y; Kao W; Wei L; Zhang F; Xu D
Int J Biochem Cell Biol; 2013 Aug; 45(8):1546-55. PubMed ID: 23702035
[TBL] [Abstract][Full Text] [Related]
18. Tetraspanin 6 (TSPAN6) negatively regulates retinoic acid-inducible gene I-like receptor-mediated immune signaling in a ubiquitination-dependent manner.
Wang Y; Tong X; Omoregie ES; Liu W; Meng S; Ye X
J Biol Chem; 2012 Oct; 287(41):34626-34. PubMed ID: 22908223
[TBL] [Abstract][Full Text] [Related]
19. A RIG-I-like receptor directs antiviral responses to a bunyavirus and is antagonized by virus-induced blockade of TRIM25-mediated ubiquitination.
Min YQ; Ning YJ; Wang H; Deng F
J Biol Chem; 2020 Jul; 295(28):9691-9711. PubMed ID: 32471869
[TBL] [Abstract][Full Text] [Related]
20. Influenza M2 protein regulates MAVS-mediated signaling pathway through interacting with MAVS and increasing ROS production.
Wang R; Zhu Y; Lin X; Ren C; Zhao J; Wang F; Gao X; Xiao R; Zhao L; Chen H; Jin M; Ma W; Zhou H
Autophagy; 2019 Jul; 15(7):1163-1181. PubMed ID: 30741586
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
